Richard Scranton serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Richard Scranton has executed 13 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 8, 2019 involved selling 19,448 shares valued at $875.2K.
Richard Scranton currently holds 16,061 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Scranton has been a net seller of PCRX stock. They have purchased $0 and sold $2.0M worth of shares.
Richard Scranton's most recent insider trade was on Nov 8, 2019, when they sold 19,448 shares at $45.00 per share.
Get notified when new Form 4 filings are submitted
| $25.37 |
| Discretionary |
| Nov 8, 2019 | PCRX | $158.9K | Option Exercise | 14,698 | $10.81 | Discretionary |
| Jun 5, 2019 | PCRX | $0 | Award | 5,000 | $N/A | Discretionary |
| Jun 5, 2019 | PCRX | $179.0K | Sale | 4,114 | $43.50 | Discretionary |
| Jun 4, 2019 | PCRX | $121.7K | Sale | 2,852 | $42.66 | Discretionary |
| Jun 4, 2019 | PCRX | $89.0K | Sale | 2,074 | $42.91 | Discretionary |
| Jun 3, 2019 | PCRX | $670.2K | Sale | 15,510 | $43.21 | Discretionary |
| Jun 3, 2019 | PCRX | $31.7K | Option Exercise | 3,010 | $10.52 | Discretionary |
| Jun 3, 2019 | PCRX | $135.1K | Option Exercise | 12,500 | $10.81 | Discretionary |
| Jun 13, 2018 | PCRX | $0 | Award | 7,875 | $N/A | Discretionary |
| Jun 4, 2018 | PCRX | $45.1K | Sale | 1,367 | $33.02 | Discretionary |
| Jun 14, 2017 | PCRX | $0 | Award | 8,750 | $N/A | Discretionary |